{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:53:28Z","timestamp":1789487608657,"version":"build-2803163510"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Observational studies have suggested improved survival among patients with colorectal cancer (CRC) who start statin therapy after diagnosis, but such studies are vulnerable to time-related biases and informative censoring.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate the association between statin initiation after CRC treatment and CRC-specific and all-cause mortality using target trial emulation.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This nationwide cohort study used Korean National Health Insurance Service claims data from January 1, 2005, through December 31, 2015. Eligible adults had newly diagnosed CRC and no statin prescriptions in the prior 6 months. Time zero was the date of first CRC treatment. A clone-censor weight approach with stabilized inverse probability of censoring weights emulated initiation within a 6-month grace period. Data were analyzed at 3-month intervals during 60 months of follow-up from August 22, 2023, to November 22, 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Initiation of any statin within 6 months after first CRC treatment vs no initiation during the same grace period.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was CRC-specific mortality; the secondary outcome was all-cause mortality. Weighted pooled logistic regression was used to estimate hazard ratios (HRs), 60-month marginal survival probabilities, and risk differences. Sensitivity analyses deliberately introduced immortal time bias and prevalent user bias. The same design was applied in a cohort with ischemic heart disease as a positive control.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 88\u202f516 patients (mean [SD] age, 62.7 [11.7] years; 56 424 [63.7%] male), 2071 initiated statins and 86\u202f445 did not. Statin initiation was associated with modestly lower CRC-specific mortality compared with noninitiation (HR, 0.95 [95% CI, 0.92-0.99]); all-cause mortality was also lower but did not reach statistical significance (HR, 0.96 [95% CI, 0.93-1.00]). The 60-month absolute differences in CRC-specific and all-cause mortality were small (1.1 percentage points [pp] [95% CI, \u22120.1 to 2.3 pp] and 2.4 pp [95% CI, 1.0-3.8 pp], respectively). Conventional analyses yielded more protective estimates. In the positive-control cohort with ischemic heart disease, statin initiation was associated with lower all-cause but not cardiovascular disease\u2013specific mortality.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this nationwide cohort study of adults treated for CRC, the survival benefit associated with statin initiation was modest and substantially attenuated compared with conventional observational estimates, suggesting that earlier protective associations may have reflected time-related biases and informative censoring.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.33680","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:00:22Z","timestamp":1789484422000},"page":"e2633680","source":"Crossref","is-referenced-by-count":0,"title":["Statin Initiation and Mortality After Colorectal Cancer Treatment"],"prefix":"10.1001","volume":"9","author":[{"given":"Hyeong-taek","family":"Woo","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, Keimyung University School of Medicine, Daegu, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aesun","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea"},{"name":"Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea"},{"name":"Cancer Research Institute, Seoul National University, Seoul, Korea"},{"name":"Interdisciplinary Program in Cancer Biology Major, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"10","key":"zoi260920r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040.","volume":"14","author":"Xi","year":"2021","journal-title":"Transl Oncol"},{"issue":"2","key":"zoi260920r2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4143\/crt.2025.264","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2022.","volume":"57","author":"Park","year":"2025","journal-title":"Cancer Res Treat"},{"issue":"1","key":"zoi260920r3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3961\/jpmph.15.029","article-title":"Diabetes mellitus and site-specific colorectal cancer risk in Korea: a case-control study.","volume":"49","author":"Woo","year":"2016","journal-title":"J Prev Med Public Health"},{"key":"zoi260920r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100794","article-title":"Association between cardiovascular risk factors and colorectal cancer: a systematic review and meta-analysis of prospective cohort studies.","volume":"34","author":"Zhang","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"2","key":"zoi260920r5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10552-014-0507-y","article-title":"Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies.","volume":"26","author":"Yao","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"12","key":"zoi260920r6","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1158\/1055-9965.EPI-06-0391","article-title":"Metabolic abnormalities and risk for colorectal cancer in the Physicians\u2019 Health Study.","volume":"15","author":"St\u00fcrmer","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi260920r7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.15430\/JCP.2015.20.2.147","article-title":"Alcohol drinking, cigarette smoking and risk of colorectal cancer in the Korean Multi-center Cancer Cohort.","volume":"20","author":"Cho","year":"2015","journal-title":"J Cancer Prev"},{"issue":"5","key":"zoi260920r8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jaccao.2025.07.001","article-title":"Cancer and cardiovascular disease: shared risk factors, mechanisms, and clinical implications: JACC: cardiooncology state-of-the-art review.","volume":"7","author":"Alhuneafat","year":"2025","journal-title":"JACC CardioOncol"},{"issue":"8","key":"zoi260920r9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA"},{"issue":"25","key":"zoi260920r10","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"zoi260920r11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/gut.2011.237495","article-title":"Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell \u201cstemness\u201d via the bone morphogenetic protein pathway.","volume":"60","author":"Kodach","year":"2011","journal-title":"Gut"},{"issue":"2","key":"zoi260920r12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways.","volume":"60","author":"Koushki","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"zoi260920r13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41416-021-01529-0","article-title":"Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer.","volume":"125","author":"Marti","year":"2021","journal-title":"Br J Cancer"},{"issue":"5","key":"zoi260920r14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/138161209787315684","article-title":"Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.","volume":"15","author":"Zhou","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"19","key":"zoi260920r15","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality.","volume":"367","author":"Nielsen","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi260920r16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1053\/j.gastro.2017.05.011","article-title":"Statin use after diagnosis of colon cancer and patient survival.","volume":"153","author":"Voorneveld","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"zoi260920r17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cac2.12252","article-title":"Impact of statins on the survival of patients with cancer: a nationwide population-based cohort study in South Korea.","volume":"42","author":"Ahn","year":"2022","journal-title":"Cancer Commun (Lond)"},{"issue":"11","key":"zoi260920r18","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3390\/jcm10112361","article-title":"Post-diagnostic statin use reduces mortality in South Korean patients with dyslipidemia and gastrointestinal cancer.","volume":"10","author":"Han","year":"2021","journal-title":"J Clin Med"},{"key":"zoi260920r19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"zoi260920r20","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"zoi260920r21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/aje\/kwr301","article-title":"Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.","volume":"175","author":"Danaei","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"5","key":"zoi260920r22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.ede.0000135174.63482.43","article-title":"A structural approach to selection bias.","volume":"15","author":"Hern\u00e1n","year":"2004","journal-title":"Epidemiology"},{"issue":"4","key":"zoi260920r23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/1740774516634335","article-title":"Adherence adjustment in the Coronary Drug Project: a call for better per-protocol effect estimates in randomized trials.","volume":"13","author":"Murray","year":"2016","journal-title":"Clin Trials"},{"issue":"8","key":"zoi260920r24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"15","key":"zoi260920r25","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMp2113319","article-title":"Methods of public health research\u2014strengthening causal inference from observational data.","volume":"385","author":"Hern\u00e1n","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"zoi260920r26","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data.","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"zoi260920r27","first-page":"799","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea.","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"2","key":"zoi260920r28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.12997\/jla.2022.11.2.103","article-title":"Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) database for research.","volume":"11","author":"Kyoung","year":"2022","journal-title":"J Lipid Atheroscler"},{"issue":"1","key":"zoi260920r29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jamaoncol.2017.2752","article-title":"Examining bias in studies of statin treatment and survival in patients with cancer.","volume":"4","author":"Emilsson","year":"2018","journal-title":"JAMA Oncol"},{"issue":"1","key":"zoi260920r30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/s12885-023-11105-9","article-title":"The association between prescription drugs and colorectal cancer prognosis: a nationwide cohort study using a medication-wide association study.","volume":"23","author":"Woo","year":"2023","journal-title":"BMC Cancer"},{"issue":"6","key":"zoi260920r31","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1158\/1055-9965.EPI-19-1455","article-title":"Prognosis of patients with colorectal cancer with diabetes according to medication adherence: a population-based cohort study.","volume":"29","author":"Choe","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"zoi260920r32","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2025056","article-title":"The delayed cancer treatment and economic inequality in Korea: results of common cancers by the time-to-surgery.","volume":"47","author":"Son","year":"2025","journal-title":"Epidemiol Health"},{"issue":"3","key":"zoi260920r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.0452","article-title":"Estimates of overall survival in patients with cancer receiving different treatment regimens: emulating hypothetical target trials in the Surveillance, Epidemiology, and End Results (SEER)\u2013Medicare linked database.","volume":"3","author":"Petito","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi260920r34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2307\/2529360","article-title":"On the treatment of grouped observations in life studies.","volume":"33","author":"Thompson","year":"1977","journal-title":"Biometrics"},{"issue":"1","key":"zoi260920r35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/2632084320961043","article-title":"Causal survival analysis: a guide to estimating intention-to-treat and per-protocol effects from randomized clinical trials with non-adherence.","volume":"2","author":"Murray","year":"2021","journal-title":"Res Methods Med Health Sci"},{"issue":"1","key":"zoi260920r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029849","article-title":"Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.","volume":"7","author":"Emberson","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"zoi260920r37","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/archinternmed.2010.182","article-title":"Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.","volume":"170","author":"Ray","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"zoi260920r38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3961\/jpmph.23.033","article-title":"Operational definitions of colorectal cancer in the Korean National Health Insurance database.","volume":"56","author":"Park","year":"2023","journal-title":"J Prev Med Public Health"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854059\/woo_2026_oi_260920_1788884303.37236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:00:23Z","timestamp":1789484423000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.33680","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}